查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1976380

立體定位手術器材市場：依產品、技術、類型、應用和最終用戶分類－2026-2032年全球預測

Stereotactic Surgery Devices Market by Product, Technology, Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，立體定位手術器械市場價值將達到 279.6 億美元，到 2026 年將成長至 295.4 億美元，到 2032 年將達到 426.5 億美元，複合年成長率為 6.21%。

主要市場統計數據
基準年 2025 279.6億美元
預計年份：2026年 295.4億美元
預測年份 2032 426.5億美元
複合年成長率 (%) 6.21%

高精度導航、整合影像工作流程和臨床醫生主導的模組化設計正在重新定義各個外科專科對立體定位手術設備的期望。

立體定位手術器材融合了精密工程、影像融合和神經外科創新技術。過去十年間，導航演算法、微型追蹤感測器和機器人輔助技術的進步，重新定義了臨床醫生對手術精確度、術中引導和流程效率的期望。這些器械旨在實現腦、耳、鼻、喉和脊椎手術的精準定位，其價值不僅體現在卓越的技術性能上，更體現在與現有影像平台的互通性、易於消毒以及對提高手術室排班效率等方面。

追蹤技術、機器人技術和軟體檢驗工作流程的整合正在推動產品開發和臨床部署模式的根本性轉變。

立體定位手術器材領域正經歷一場變革，這場變革是由技術、臨床和商業性因素的共同作用所驅動的。首先，光學和電磁追蹤技術的成熟拓展了無框架手術的應用範圍，實現了微創手術流程，並提高了患者的舒適度。同時，機器人輔助技術的興起為致動器精度和外科醫生與器械的協作引入了新的範式，並將討論的重點從器械的替代轉向了手術能力的提升。

關稅導致供應鏈重組，製造地因地區而異，這重新定義了 2025 年的籌資策略和設備設計重點。

美國於2025年實施的關稅措施加劇了貿易摩擦，對立體定位手術器械及其組件的全球供應鏈造成了影響。對精密電子元件、追蹤感測器和某些機器人子系統徵收的進口關稅導致依賴跨境組件採購的製造商成本上升。為應對這一局面，多家公司加快了關鍵供應鏈的本地化進程，審查了供應商契約，並探索了近岸外包策略以降低關稅波動風險。這些調整導致前置作業時間短期中斷，並促使採購組織重新評估庫存策略。

將最終用戶、技術、產品、設備類型和臨床應用聯繫起來的多維細分框架揭示了每種醫療保健環境和程序的不同價值促進因素。

基於最終用戶的細分將醫療機構分為門診手術中心、醫院和專科診所。門診手術中心進一步細分為醫院附屬機構和獨立機構，而醫院則根據其性質（私立、公立或教學醫院）進行區分。這種結構突顯了醫療環境對採購週期、資本規劃和臨床容量需求的影響，並揭示了實施時間的差異。具體而言，獨立門診中心往往優先考慮快速周轉率和成本效益，而教學醫院則往往更注重與培訓和研究計畫的整合。

美洲、歐洲、中東和非洲以及亞太地區在實施路徑上的區域差異反映了基礎設施成熟度、償還模式以及特定區域的證據生成優先事項。

立體定位手術器材的區域趨勢清楚地揭示了需求促進因素，這些因素主要受美洲、歐洲、中東、非洲和亞太地區醫療基礎設施成熟度、報銷標準和區域法規環境。在美洲，大型三級醫療機構和器械開發商的高度集中推動了先進導航和機器人系統的早期應用，而門診手術中心則擴大採用無框架和無標記解決方案，以支持高通量選擇性手術。在北美，從研究階段到常規應用的過渡通常是由可驗證的工作流程改進以及與手術報銷系統的契合所驅動的。

在競爭激烈的環境中，整合導航生態系統、策略夥伴關係以及透過生命週期服務來實現盈利是設備製造商獲得優勢的關鍵差異化因素。

立體定位手術器械領域的主要企業趨勢在於，它們致力於在硬體、軟體和服務一體化體系中進行策略性定位，主要企業正著力投資於整合導航生態系統，而非獨立設備。一些現有設備製造商正透過有針對性的收購來擴展產品組合，以增加軟體規劃套件、感測器技術或配套的機器人模組。同時，敏捷的創新者則專注於利用低成本、高精度的追蹤技術和創新的無標記配準演算法來實現差異化競爭。這種競爭格局進一步凸顯了互通性、軟體版本合規性以及旨在縮短臨床醫生學習曲線的完善培訓計劃的重要性。

為了促進推廣應用和保護長期價值，應優先考慮模組化設計、可靠的臨床證據、靈活的商業模式和供應鏈彈性。

致力於從立體定位手術器材中挖掘臨床和商業性價值的產業領導者應優先採取一系列切實可行的步驟，使產品開發與臨床工作流程和醫療機構的採購行為保持一致。首先，投資於模組化架構，實現硬體模組和軟體應用的逐步升級。這使得客戶能夠在保護現有投資的同時引入新功能。其次，透過多中心合作研究，重點在於手術效率、併發症減少和可重複的準確性，從而累積更有力的臨床證據。這些數據將有助於提升採購談判的競爭力，並加速臨床醫師對產品的接受度。第三，發展一種靈活的商業模式，結合資本投入、訂閱和基於結果的服務要素，以適應醫院和門診中心不同的預算需求。

透過對臨床醫生的訪談、醫療設備文件、監管記錄和技術評估進行嚴格的證據分析，檢驗臨床和營運方面的見解。

本研究結合了對臨床醫生、採購經理和行業高管的定性訪談，以及對監管申報文件、同行評審的臨床研究和產品文件的系統性回顧。研究也與神經外科醫生、耳鼻喉科醫生、脊椎外科醫生和手術室管理人員進行了半結構式討論，以此作為主要資訊來源，了解實際工作流程的限制、推廣應用的阻礙因素以及所需的功能集。次要分析則著重於醫療設備手冊、監管核准和臨床試驗通訊協定，以檢驗技術聲明並了解證據產生的時間軸。在整個研究過程中，資訊來源三角驗證確保了報告的臨床結果與器械規格之間的一致性。

一體化的臨床平台、檢驗的工作流程和強大的供應策略決定了哪些創新能帶來持續的臨床和商業性成功。

立體定位手術器械正從單一工具發展成為整合式臨床平台。這些平台必須具備可驗證的手術價值、無縫的互通性以及穩健的供應策略。技術融合、軟體賦能器材不斷變化的監管要求以及貿易相關供應鏈的轉變等多種因素，迫使相關人員在創新與服務、培訓和長期升級等實際考量之間尋求平衡。臨床醫生日益需要能夠整合到現有影像生態系統中，並顯著降低手術複雜性和變異性的器械。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 立體定位外科器械市場：依產品分類

  • 配件
  • 導航系統
    • 硬體模組
    • 軟體
  • 機器人系統
    • 主動系統
    • 被動系統

第9章 立體定位外科器械市場：依技術分類

  • 電磁追蹤
    • 高頻
    • 低頻
  • 光學追蹤
    • 紅外線基座
    • 雷射基座

第10章：立體定位外科器械市場：按類型分類

  • 基於幀的設備
  • 無邊框設備
    • 標記底座
    • 無標記

第11章 立體定位外科器械市場：按應用領域分類

  • 神經外科
    • 深部腦部刺激療法
    • 腫瘤切除
  • 耳鼻喉科手術
    • 鼻竇手術
    • 腫瘤手術
  • 脊椎手術
    • 減壓手術
    • 固定

第12章：立體定位外科器械市場：依最終用戶分類

  • 門診手術中心
    • 醫院門診手術中心
    • 獨立門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院
    • 教學醫院
  • 專科診所

第13章 立體定位外科器械市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：立體定位外科器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：立體定位外科器械市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 美國立體定位外科器械市場

第17章 中國立體定位外科器械市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accuray Inc.
  • Adeor Medical AG
  • Brainlab AG
  • Computerized Imaging Reference Systems, Inc.
  • Elekta AB
  • FHC Inc.
  • Harvard Bioscience, Inc.
  • Hitachi Medical Systems
  • IBA
  • Inomed Medizintechnik GmbH
  • Integra Life Sciences
  • Koninklijke Philips NV
  • Medtronic PLC
  • Micromar Ind.
  • Modus Medical Devices
  • Monteris Medical
  • Nexstim PLC
  • Nico Corporation
  • PMT Corporation
  • Raysearch Laboratories
  • Renishaw PLC
  • Siemens Healthcare Private Limited
  • Stayker Corporation
  • Zeiss Group
Product Code: MRR-DD0700E81DCF

The Stereotactic Surgery Devices Market was valued at USD 27.96 billion in 2025 and is projected to grow to USD 29.54 billion in 2026, with a CAGR of 6.21%, reaching USD 42.65 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 27.96 billion
Estimated Year [2026] USD 29.54 billion
Forecast Year [2032] USD 42.65 billion
CAGR (%) 6.21%

High-precision navigation, integrated imaging workflows, and clinician-driven modularity are redefining expectations for stereotactic surgery devices across surgical specialties

Stereotactic surgery devices are at the intersection of precision engineering, imaging integration, and neurosurgical innovation. Over the last decade, advances in navigation algorithms, miniaturized tracking sensors, and robotic assistance have reshaped clinician expectations for accuracy, intraoperative guidance, and workflow efficiency. These devices, designed to enable precise target localization for interventions in the brain, ear, nose and throat, and spine, are increasingly evaluated not only on technical performance but also on interoperability with existing imaging platforms, ease of sterilization, and throughput implications for operating room schedules.

Clinicians and procurement leaders now demand evidence of reproducible accuracy and demonstrable reductions in procedure time and complications. Consequently, device development has prioritized modular architectures that allow incremental upgrades to hardware modules and software without disrupting established clinical protocols. As a result, hospitals, ambulatory surgical centers, and specialty clinics are reconsidering procurement criteria to emphasize lifecycle flexibility and total cost of ownership, while research institutions and clinical leaders continue to refine indications and procedural best practices through multi-center collaborations and registries.

Convergence of tracking, robotics, and software-validated workflows is driving a fundamental reorientation of product development and clinical adoption patterns

The landscape of stereotactic surgery devices is undergoing transformative shifts driven by converging technological, clinical, and commercial forces. First, the maturation of optical and electromagnetic tracking technologies has expanded the procedural envelope for frameless approaches, enabling less invasive workflows and improved patient comfort. Simultaneously, the rise of robotic assistance has introduced new paradigms in actuator precision and surgeon-device collaboration, shifting the conversation from device replacement to augmentation of surgical capability.

Second, software-defined functionality has become a differentiator. Advanced planning suites, real-time registration updates, and machine-assisted trajectory optimization are migrating from adjunct tools to core components of navigation ecosystems. This transition compels manufacturers to prioritize software validation, user interface ergonomics, and secure data architectures. Third, reimbursement policies and evolving regulatory pathways for software as a medical device are influencing product roadmaps, prompting earlier stakeholder engagement with payers and regulators. Together, these shifts mean that competitive advantage now resides in the ability to deliver end-to-end clinical value-combining hardware precision, validated software, and clear operational benefits for care providers.

Tariff-induced supply chain recalibrations and regional manufacturing shifts reshaped procurement strategies and device design priorities throughout 2025

The imposition of tariffs in the United States during 2025 introduced a layer of trade friction that affected the global supply chain for stereotactic surgery devices and their subcomponents. Import duties on precision electronics, tracking sensors, and certain robotic subsystems increased costs for manufacturers who relied on cross-border component sourcing. In response, several firms accelerated localization of critical supply lines, re-evaluated supplier contracts, and explored nearshoring strategies to mitigate exposure to tariff volatility. These adjustments triggered short-term disruptions in lead times and prompted a reassessment of inventory strategies within procurement organizations.

Manufacturers facing higher input costs made targeted decisions to absorb some expenses while passing others through in the form of selective price adjustments tied to premium feature sets. Clinical customers and distributors adapted by prioritizing purchases that delivered measurable clinical efficiencies or that supported long-term service agreements. Over time, the tariff-driven dynamics spurred innovation in product design to reduce reliance on tariffed components, and they incentivized partnerships focused on regional manufacturing hubs to protect access and control operating margins. As a consequence, strategy conversations now routinely include trade policy scenarios as a material factor in supply chain planning and product lifecycle decisions.

A multidimensional segmentation framework linking end user, technology, product, device type, and clinical application reveals differentiated value drivers across care settings and procedures

Segmentation based on end user distinguishes ambulatory surgical centers, hospitals, and specialty clinics, with ambulatory surgical centers further parsed into hospital-based and independent facilities, and hospitals differentiated across private, public, and teaching institutions; this structure highlights how care setting influences procurement cycles, capital planning, and clinical throughput imperatives, revealing divergent adoption timelines where independent ambulatory centers often prioritize rapid turnover and cost efficiency while teaching hospitals emphasize integration with training and research programs.

Technology segmentation separates electromagnetic tracking and optical tracking, with electromagnetic tracking subdivided into high frequency and low frequency approaches and optical tracking distinguished by infrared-based and laser-based implementations; these technological delineations matter because frequency characteristics, line-of-sight limitations, and susceptibility to intraoperative interference drive selection criteria for specific procedures, influencing whether a facility opts for an electromagnetic solution with robust line-insensitive performance or an optical system that offers high-resolution visualization under optimal sightlines.

Product segmentation groups accessories, navigation systems, and robotic systems, where navigation systems break down into hardware modules and software components and robotic systems split into active and passive architectures; the interplay between hardware modularity and software capabilities determines upgrade pathways and long-term service relationships, while the choice between active and passive robotic assistance reflects clinical philosophy regarding the degree of automation and surgeon control.

Type segmentation contrasts frame-based and frameless devices, with frame-based devices narrowed to stereotactic frames and frameless devices categorized into marker-based and markerless approaches; this typology matters for patient experience and procedural logistics because frame-based workflows often involve preoperative fixation and imaging coordination, whereas frameless markerless systems streamline patient preparation and can reduce anesthesia time in selected procedures.

Application segmentation includes brain surgery, ENT surgery, and spine surgery, with brain procedures further classified into deep brain stimulation and tumor resection, ENT procedures into sinus surgery and tumor surgery, and spine procedures into decompression and fusion; these clinical subdivisions underscore how device requirements vary by target anatomy, required trajectory precision, and the need for intraoperative adaptability, which in turn shapes validation studies, surgeon training programs, and post-market evidence generation strategies.

Distinct regional adoption pathways reflect infrastructure maturity, reimbursement paradigms, and localized evidence generation priorities across the Americas, EMEA, and Asia-Pacific

Regional dynamics for stereotactic surgery devices show distinct demand drivers across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each shaped by healthcare infrastructure maturity, reimbursement norms, and local regulatory environments. In the Americas, large tertiary centers and a high concentration of device innovators drive early adoption of advanced navigation and robotic systems, while ambulatory surgical centers expand uptake of frameless and markerless solutions that support high-throughput elective procedures. Transitioning from research to routine use in North America often hinges on demonstrable workflow efficiencies and alignment with procedural reimbursement.

In Europe, Middle East & Africa, heterogeneous regulatory pathways and varied hospital funding models create a mosaic of adoption patterns; several nations emphasize cost-conscious procurement and high-value bundles that include training and long-term service, whereas centers of excellence in Western Europe often pilot cutting-edge tracking and robotic hybrids. In the Asia-Pacific region, rapid hospital expansion, investment in diagnostic imaging capacity, and growing local manufacturing capabilities have accelerated adoption across both private and public hospital segments, with particular momentum in teaching hospitals that integrate stereotactic platforms into specialty program growth. Across all regions, clinical partnerships and localized evidence generation remain central to unlocking durable adoption and payer acceptance.

Competitive dynamics favor integrated navigation ecosystems, strategic partnerships, and lifecycle service monetization as core differentiators for device companies

Key company dynamics in the stereotactic devices arena center on strategic positioning along the hardware-software-service continuum, with leading firms investing in integrated navigation ecosystems rather than standalone instruments. Several incumbent device manufacturers have expanded portfolios through targeted acquisitions that add software planning suites, sensor technologies, or complementary robotic modules, while nimble innovators have focused on niche differentiation through lower-cost, high-precision tracking or novel markerless registration algorithms. This competitive mix intensifies emphasis on interoperability, regulatory compliance for software releases, and robust training programs to shorten clinician learning curves.

Partnerships between device makers, imaging vendors, and health systems are increasingly common, enabling co-development of validated workflows and real-world evidence studies. Service models are evolving from traditional warranty and maintenance contracts toward value-based agreements tied to procedural outcomes and uptime guarantees. For new entrants, success frequently depends on demonstrating clear clinical advantages in specific applications-such as deep brain stimulation trajectory accuracy or sinus surgery navigation time reduction-while incumbents leverage scale, global service networks, and established hospital relationships to protect installed-base revenue streams. Investors and strategic partners are watching closely for differentiators in software intellectual property, sensor fusion capabilities, and lifecycle monetization strategies.

Prioritize modular design, robust clinical evidence, flexible commercial models, and supply chain resilience to accelerate adoption and protect long-term value

Industry leaders seeking to capture clinical and commercial value from stereotactic surgery devices should prioritize a set of actionable moves that align product development with clinical workflows and institutional buying behavior. First, invest in modular architectures that allow incremental upgrades to hardware modules and software applications, enabling customers to protect prior investments while adopting new capabilities. Second, build stronger clinical evidence through multi-center studies that emphasize procedural efficiency, complication reduction, and reproducible accuracy; such data support procurement discussions and accelerate clinician acceptance. Third, develop flexible commercial models that combine capital, subscription, and outcomes-linked service components to address diverse hospital and ambulatory center budgets.

Additionally, focus on supply chain resilience by qualifying secondary suppliers for critical components and exploring regional manufacturing to hedge against trade disruptions. Strengthen post-market support and training programs with simulation-based curricula that shorten the learning curve and increase procedural throughput. Finally, proactively engage with regulators and payers to clarify pathways for software updates and to articulate the clinical and economic value of navigation-enabled care. Executed together, these recommendations will help leaders minimize adoption friction, protect margins, and translate technical differentiation into measurable clinical impact.

A rigorous evidence synthesis combining clinician interviews, device documentation, regulatory records, and technology assessments to validate clinical and operational insights

This research synthesizes primary qualitative interviews with clinicians, procurement leaders, and industry executives alongside a structured review of regulatory filings, peer-reviewed clinical studies, and product literature. Primary inputs included semi-structured discussions with neurosurgeons, ENT specialists, spine surgeons, and operating room managers to capture real-world workflow constraints, adoption inhibitors, and desired feature sets. Secondary analysis encompassed device manuals, regulatory approvals, and clinical trial protocols to verify technical claims and to understand evidence generation timelines. Throughout the research, source triangulation ensured consistency between reported clinical outcomes and device specifications.

Analytical methods combined thematic coding of interview transcripts to identify recurring adoption drivers with technology assessment frameworks that evaluated tracking accuracy, latency, and integration complexity. Supply chain analysis mapped critical component dependencies and logistics vulnerabilities exposed by trade policy changes. Care was taken to verify factual assertions against publicly available regulatory documents and peer-reviewed clinical literature. Where gaps in evidence existed, the analysis identified priority areas for future clinical evaluation and recommended approaches for pragmatic validation within hospital settings.

Integrated clinical platforms, validated workflows, and resilient supply strategies will determine which innovations translate into sustained clinical and commercial success

Stereotactic surgery devices are transitioning from discrete tools to integrated clinical platforms that must deliver demonstrable procedural value, seamless interoperability, and resilient supply strategies. The combined forces of technological convergence, evolving regulatory expectations for software-enabled devices, and trade-related supply chain shifts mean that stakeholders must balance innovation with practical considerations around service, training, and long-term upgradeability. Clinicians increasingly seek devices that integrate into established imaging ecosystems and that provide clear reductions in procedure complexity and variability.

For manufacturers, the path ahead requires investing in clinical evidence, building flexible commercial arrangements, and strengthening regional supply networks to mitigate policy-driven disruptions. For providers, prioritizing procurement decisions based on lifecycle value and total workflow impact rather than initial acquisition price will improve patient outcomes and operational efficiency. In sum, the community of device developers, healthcare providers, and policy makers must collaborate to ensure that technological advances translate into safer, more accessible, and more cost-effective stereotactic care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Stereotactic Surgery Devices Market, by Product

  • 8.1. Accessories
  • 8.2. Navigation Systems
    • 8.2.1. Hardware Modules
    • 8.2.2. Software
  • 8.3. Robotic Systems
    • 8.3.1. Active Systems
    • 8.3.2. Passive Systems

9. Stereotactic Surgery Devices Market, by Technology

  • 9.1. Electromagnetic Tracking
    • 9.1.1. High Frequency
    • 9.1.2. Low Frequency
  • 9.2. Optical Tracking
    • 9.2.1. Infrared Based
    • 9.2.2. Laser Based

10. Stereotactic Surgery Devices Market, by Type

  • 10.1. Frame Based Devices
  • 10.2. Frameless Devices
    • 10.2.1. Marker Based
    • 10.2.2. Markerless

11. Stereotactic Surgery Devices Market, by Application

  • 11.1. Brain Surgery
    • 11.1.1. Deep Brain Stimulation
    • 11.1.2. Tumor Resection
  • 11.2. Ent Surgery
    • 11.2.1. Sinus Surgery
    • 11.2.2. Tumor Surgery
  • 11.3. Spine Surgery
    • 11.3.1. Decompression
    • 11.3.2. Fusion

12. Stereotactic Surgery Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
    • 12.1.1. Hospital-Based Ascs
    • 12.1.2. Independent Ascs
  • 12.2. Hospitals
    • 12.2.1. Private Hospitals
    • 12.2.2. Public Hospitals
    • 12.2.3. Teaching Hospitals
  • 12.3. Specialty Clinics

13. Stereotactic Surgery Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Stereotactic Surgery Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Stereotactic Surgery Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Stereotactic Surgery Devices Market

17. China Stereotactic Surgery Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accuray Inc.
  • 18.6. Adeor Medical AG
  • 18.7. Brainlab AG
  • 18.8. Computerized Imaging Reference Systems, Inc.
  • 18.9. Elekta AB
  • 18.10. FHC Inc.
  • 18.11. Harvard Bioscience, Inc.
  • 18.12. Hitachi Medical Systems
  • 18.13. IBA
  • 18.14. Inomed Medizintechnik GmbH
  • 18.15. Integra Life Sciences
  • 18.16. Koninklijke Philips N.V.
  • 18.17. Medtronic PLC
  • 18.18. Micromar Ind.
  • 18.19. Modus Medical Devices
  • 18.20. Monteris Medical
  • 18.21. Nexstim PLC
  • 18.22. Nico Corporation
  • 18.23. PMT Corporation
  • 18.24. Raysearch Laboratories
  • 18.25. Renishaw PLC
  • 18.26. Siemens Healthcare Private Limited
  • 18.27. Stayker Corporation
  • 18.28. Zeiss Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES STEREOTACTIC SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA STEREOTACTIC SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 265. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 267. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 268. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 271. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 272. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 274. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 276. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 277. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 278. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 280. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS STEREOT